In December, Interfarma“s Compliance Committee concluded the first consolidated text of its New Code of Conduct, result of previous work of ten Working Groups, started in 2019. Each of the groups focused on a specific issue regarding Compliance practice for the Pharmaceutical Industry.
The current text will now undergo an external review for formatting and harmonization. This is Interfarma“s Code of Conduct fifth version and its fourth revision.
Before it is publicly available the Draft will go under approval of Interfarma´s Management Committee, Board of Directors, and a final approval at the General Assembly, under its Bylaws.
At the same time, Interfarma will start developing capacity building and certification platforms that should be carried out by all employees of its members.